BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Staging
24 results:

  • 1. Analysis of the mlh1, MLH2, MLH6, PMS2 genes and their correlations with clinical data in rectal mucinous adenocarcinoma.
    Graur F; Puia A; Mois E; Pop P; Berar M; Elisei R; Zaharie F; Nechita V; Rusu I; Buiga R; Puia C; Al Hajjar N
    Ann Ital Chir; 2022; 93():188-194. PubMed ID: 34807001
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinicopathological, Immunohistochemical, and
    Mousavi M; Goodarzi MT; Kassaee SM; Jafari Heidarloo A; Fathi M
    Arch Iran Med; 2021 Feb; 24(2):86-93. PubMed ID: 33636974
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [18F]FDG PET/MRI in rectal cancer.
    Crimì F; Valeggia S; Baffoni L; Stramare R; Lacognata C; Spolverato G; Albertoni L; Spimpolo A; Evangelista L; Zucchetta P; Cecchin D; Pucciarelli S
    Ann Nucl Med; 2021 Mar; 35(3):281-290. PubMed ID: 33517562
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer.
    Lee CT; Chow NH; Chen YL; Ho CL; Yeh YM; Lin SC; Lin PC; Lin BW; Chu CA; Tsai HW; Lee JC
    Pathol Res Pract; 2021 Jan; 217():153288. PubMed ID: 33276219
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Different surgical outcome and follow-up status between dMMR and pMMR colorectal cancer patients who fulfilled with Amsterdam-II criteria.
    Sun CY; Chiang JM; Chen TC; Hung HY; You JF
    World J Surg Oncol; 2020 Aug; 18(1):195. PubMed ID: 32767993
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Immunoexpression of TS, p53, COX2, EGFR, MSH6 and mlh1 biomarkers and its correlation with degree of differentiation, tumor staging and prognostic factors in colorectal adenocarcinoma: a retrospective longitudinal study.
    Batista WR; Santos G; Vital FMR; Matos D
    Sao Paulo Med J; 2019 May; 137(1):33-38. PubMed ID: 31116268
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic values of detecting MSI phenotypes in colorectal carcinoma by immunohistochemical method compared to molecular investigation.
    Trabelsi M; Farah F; Blel A; Jaafoura MH; Kharrat M; Rammeh S
    Tunis Med; 2017 Dec; 95(12):229-236. PubMed ID: 29878286
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Microcystic, Elongated, and Fragmented Pattern Invasion in Ovarian Endometrioid Carcinoma: Immunohistochemical Profile and Prognostic Implications.
    Goldberg A; Hand L; DeCotiis D; Rosenblum N; Chan J
    Int J Gynecol Pathol; 2018 Jan; 37(1):44-51. PubMed ID: 28319570
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genetic screening in young women diagnosed with endometrial cancer.
    Pecorino B; Rubino C; Guardalà VF; Galia A; Scollo P
    J Gynecol Oncol; 2017 Jan; 28(1):e4. PubMed ID: 27670258
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Distinct Clinicopathological Patterns of Mismatch Repair Status in colorectal cancer Stratified by KRAS Mutations.
    Li W; Zhi W; Zou S; Qiu T; Ling Y; Shan L; Shi S; Ying J
    PLoS One; 2015; 10(6):e0128202. PubMed ID: 26042813
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Can a biomarker-based scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer?
    Hur H; Kim NK; Min BS; Baik SH; Lee KY; Koom WS; Ahn JB; Kim H
    Dis Colon Rectum; 2014 May; 57(5):592-601. PubMed ID: 24819099
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. BRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-analysis.
    Chen D; Huang JF; Liu K; Zhang LQ; Yang Z; Chuai ZR; Wang YX; Shi DC; Huang Q; Fu WL
    PLoS One; 2014; 9(3):e90607. PubMed ID: 24594804
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Lynch syndrome from a surgeon perspective: retrospective study of clinical impact of mismatch repair protein expression analysis in colorectal cancer patients less than 50 years old.
    Baiocchi GL; Portolani N; Vermi W; Baronchelli C; Gheza F; Zogno C; Scaglia A; Marchina E; Tiberio GA; Giulini SM
    BMC Surg; 2014 Feb; 14():9. PubMed ID: 24533633
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Incidence and histological features of colorectal cancer in the Northern Cape Province, South Africa.
    Wentink MQ; Räkers M; Stupart DA; Algar U; Ramesar R; Goldberg PA
    S Afr J Surg; 2010 Nov; 48(4):109-13. PubMed ID: 21542398
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds.
    Grindedal EM; Renkonen-Sinisalo L; Vasen H; Evans G; Sala P; Blanco I; Gronwald J; Apold J; Eccles DM; Sánchez AA; Sampson J; Järvinen HJ; Bertario L; Crawford GC; Stormorken AT; Maehle L; Moller P
    J Med Genet; 2010 Feb; 47(2):99-102. PubMed ID: 19635727
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Analysis of hmlh1 and hMSH2 expression in cisplatin-treated ovarian cancer patients.
    Magnowska M; Surowiak P; Nowak-Markwitz E; Michalak M; Magnowski P; Rokita W; Kedzia H; Zabel M; Spaczyński M
    Ginekol Pol; 2008 Dec; 79(12):826-34. PubMed ID: 19175039
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Immunohistochemistry of proteins for DNA mismatch repair in correlation to prognostic factors of mammarian cancer.
    Köster F; Schröer A; Fischer D; Horn AK; Diedrich K; Friedrich M
    Oncol Rep; 2007 May; 17(5):1223-7. PubMed ID: 17390069
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Genetic factors and colorectal cancers development: therapeutic impact].
    Olschwang S; Viret F; Monges G; Seitz J; Sevenet N; Tiret E; Milano G; Birnbaum D; Bertucci F
    Med Sci (Paris); 2006 Jan; 22 Spec No 1():45-9. PubMed ID: 16705943
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Activity of the National Oncology R&D Consortium in 2004].
    Tímár J;
    Magy Onkol; 2005; 49(1):3-7. PubMed ID: 15902326
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Loss of heterozygosity: an independent prognostic factor of colorectal cancer.
    Chang SC; Lin JK; Lin TC; Liang WY
    World J Gastroenterol; 2005 Feb; 11(6):778-84. PubMed ID: 15682467
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.